Oppenheimer & CO Inc Lantheus Holdings, Inc. Transaction History
Oppenheimer & CO Inc
- $7.23 Billion
- Q2 2025
A detailed history of Oppenheimer & CO Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 2,856 shares of LNTH stock, worth $152,938. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,856
Previous 2,313
23.48%
Holding current value
$152,938
Previous $225,000
3.56%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LNTH
# of Institutions
543Shares Held
79.2MCall Options Held
710KPut Options Held
433K-
Black Rock Inc. New York, NY8.6MShares$460 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X06.94MShares$372 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.84MShares$366 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA6.72MShares$360 Million2.47% of portfolio
-
State Street Corp Boston, MA2.56MShares$137 Million0.01% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $3.68B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...